Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001493152-26-031095
Filing Date
2026-06-29
Accepted
2026-06-29 16:31:44
Documents
1
Effectiveness Date
2026-06-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10217
  Complete submission text file 0001493152-26-031095.txt   11528
Mailing Address 9350 KIRBY DRIVE SUITE 300 HOUSTON TX 77054
Business Address 9350 KIRBY DRIVE SUITE 300 HOUSTON TX 77054 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-588997 | Film No.: 261136175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)